OxyContin Patent Settlement Limits Impax Market Share Even With ANDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Generic manufacturer could begin selling either its own product or an authorized generic of the controlled-release opioid as early as Jan. 1, 2016.